Regulatory Activities: In April 2025, Sanofi and Regeneron Pharma received approval from the U.S. FDA for Dupixent (dupilumab) to treat adults and adolescents aged 12 years and older with chronic ...

The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for ...

When a super investor of India or like we call them, Warren Buffetts of India is interested in a stock/company, it becomes very apparent by their holdings in those companies. Ace investor Ashish ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

Potential tariffs on imported medications could dramatically increase costs for American consumers and worsen existing drug ...

Trump continues to threaten new tariffs on Film and Pharma. Buyers pull back causing sellers to get anxious. The Saudi’s are mad as hell and announce June production increases. Bonds decline; yields ...

S&P 500 E-Mini futures (ESM25) are trending down -0.82% this morning as the latest batch of corporate earnings reports ...

Stocks fell to start the week as investors hoping for news of trade deals instead had to grapple with another set of tariffs.

Concerns around the proposed US Biosecure Act, lingering trade tensions, and the spectre of potential US tariffs are ...

Key insights include the rise of precision medicine, regulatory compliance, and the significant contributions of major players like BASF and Johnson Matthey. Get comprehensive data and competitive ...

Oral dosage powder packaging machines are specialized equipment used in packaging powdered substances in various formats such ...

New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states ...